FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096418548> ?p ?o ?g. }

• W2096418548 endingPage "5" @default.
• W2096418548 startingPage "5" @default.
• W2096418548 abstract "Serum biomarkers may be useful in the evaluation of suspected head and neck squamous cell cancer (HNSCC) and as indicators of treatment success or failure in adjuvant and chemopreventive clinical trials.To determine serum cytokine and chemokine concentrations altered in patients with HNSCC compared with healthy volunteers to identify potential biomarkers.A retrospective experimental laboratory study at Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport. Serum samples from 50 patients with stages II, III, and IV HNSCC and 20 healthy volunteers were available for study. Primary tumor sites represented in the patient group included the nasal cavity, oral cavity, oropharynx, hypopharynx, and larynx.Following institutional review approval and written informed consent, blood samples were drawn from patients. No intervention, to include any kind of diagnostic workup or treatment, was provided to patients during the course of this study.The main outcome measures were the quantification of cytokine and chemokine concentrations in serum samples. Luminex multiplex panel technology was used for simultaneous measurement of 18 analytes, including fibroblast growth factor 2, granulocyte-macrophage colony-stimulating factor, growth-related oncogene, interferon (IFN)-γ, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13, inducible protein (IP)-10, soluble CD40 ligand, tumor necrosis factor, and vascular endothelial growth factor.The serum samples of patients with HNSCC contained lower levels of IFN-γ (mean patient serum level, 6.08 pg/mL, compared with the mean control level, 26.20 pg/mL; P = .004), IL-13 (mean patient serum level, 2.85 pg/mL, compared with the control mean level, 7.23 pg/mL; P = .02), and macrophage inflammatory protein-1β (MIP-1β) (mean patient serum level, 14.91 pg/mL, compared with the mean control level, 28.98 pg/mL; P = .004), and elevated levels of IP-10 (mean patient serum level, 359.24 pg/mL, compared with mean control level, 216.40 pg/mL; P = .04). All other markers tested were not significantly different between patients with cancer and controls.This pilot study demonstrated a significant decrease in serum IFN-γ, IL-13, and MIP-1β levels and a significant elevation of serum IP-10 concentration in patients with HNSCC, irrespective of primary tumor site. If validated in larger, independent studies, these serum biomarkers may be useful in the diagnosis and treatment of HNSCC. In the future, a defined, multianalyte screening panel could facilitate early diagnosis of HNSCC, allowing for earlier treatment and thereby reducing patient mortality." @default.
• W2096418548 created "2016-06-24" @default.
• W2096418548 creator A5009104353 @default.
• W2096418548 creator A5031243602 @default.
• W2096418548 creator A5040827308 @default.
• W2096418548 creator A5076122892 @default.
• W2096418548 creator A5076481030 @default.
• W2096418548 creator A5081812709 @default.
• W2096418548 date "2014-01-01" @default.
• W2096418548 modified "2023-09-27" @default.
• W2096418548 title "Serum Biomarkers in Head and Neck Squamous Cell Cancer" @default.
• W2096418548 cites W1907773692 @default.
• W2096418548 cites W1964730223 @default.
• W2096418548 cites W1969313157 @default.
• W2096418548 cites W1975766287 @default.
• W2096418548 cites W1987900382 @default.
• W2096418548 cites W2006733013 @default.
• W2096418548 cites W2008479676 @default.
• W2096418548 cites W2021237871 @default.
• W2096418548 cites W2026841252 @default.
• W2096418548 cites W2028710588 @default.
• W2096418548 cites W2030192481 @default.
• W2096418548 cites W2034849370 @default.
• W2096418548 cites W2043529701 @default.
• W2096418548 cites W2057291465 @default.
• W2096418548 cites W2060099775 @default.
• W2096418548 cites W2062529851 @default.
• W2096418548 cites W2065801967 @default.
• W2096418548 cites W2066064151 @default.
• W2096418548 cites W2081951192 @default.
• W2096418548 cites W2089855744 @default.
• W2096418548 cites W2096906078 @default.
• W2096418548 cites W2118471749 @default.
• W2096418548 cites W2124144068 @default.
• W2096418548 cites W2128055246 @default.
• W2096418548 cites W2128958899 @default.
• W2096418548 cites W2143623671 @default.
• W2096418548 cites W2151941382 @default.
• W2096418548 cites W2154007598 @default.
• W2096418548 cites W2166579846 @default.
• W2096418548 cites W2169929180 @default.
• W2096418548 cites W2408499012 @default.
• W2096418548 cites W2410571472 @default.
• W2096418548 cites W2499914277 @default.
• W2096418548 cites W2549741141 @default.
• W2096418548 doi "https://doi.org/10.1001/jamaoto.2013.5688" @default.
• W2096418548 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24232368" @default.
• W2096418548 hasPublicationYear "2014" @default.
• W2096418548 type Work @default.
• W2096418548 sameAs 2096418548 @default.
• W2096418548 citedByCount "35" @default.
• W2096418548 countsByYear W20964185482014 @default.
• W2096418548 countsByYear W20964185482015 @default.
• W2096418548 countsByYear W20964185482016 @default.
• W2096418548 countsByYear W20964185482017 @default.
• W2096418548 countsByYear W20964185482018 @default.
• W2096418548 countsByYear W20964185482019 @default.
• W2096418548 countsByYear W20964185482020 @default.
• W2096418548 countsByYear W20964185482021 @default.
• W2096418548 countsByYear W20964185482022 @default.
• W2096418548 countsByYear W20964185482023 @default.
• W2096418548 crossrefType "journal-article" @default.
• W2096418548 hasAuthorship W2096418548A5009104353 @default.
• W2096418548 hasAuthorship W2096418548A5031243602 @default.
• W2096418548 hasAuthorship W2096418548A5040827308 @default.
• W2096418548 hasAuthorship W2096418548A5076122892 @default.
• W2096418548 hasAuthorship W2096418548A5076481030 @default.
• W2096418548 hasAuthorship W2096418548A5081812709 @default.
• W2096418548 hasBestOaLocation W20964185481 @default.
• W2096418548 hasConcept C121608353 @default.
• W2096418548 hasConcept C126322002 @default.
• W2096418548 hasConcept C143998085 @default.
• W2096418548 hasConcept C2776530083 @default.
• W2096418548 hasConcept C2776833033 @default.
• W2096418548 hasConcept C2777863537 @default.
• W2096418548 hasConcept C2778690821 @default.
• W2096418548 hasConcept C71924100 @default.
• W2096418548 hasConcept C90924648 @default.
• W2096418548 hasConceptScore W2096418548C121608353 @default.
• W2096418548 hasConceptScore W2096418548C126322002 @default.
• W2096418548 hasConceptScore W2096418548C143998085 @default.
• W2096418548 hasConceptScore W2096418548C2776530083 @default.
• W2096418548 hasConceptScore W2096418548C2776833033 @default.
• W2096418548 hasConceptScore W2096418548C2777863537 @default.
• W2096418548 hasConceptScore W2096418548C2778690821 @default.
• W2096418548 hasConceptScore W2096418548C71924100 @default.
• W2096418548 hasConceptScore W2096418548C90924648 @default.
• W2096418548 hasIssue "1" @default.
• W2096418548 hasLocation W20964185481 @default.
• W2096418548 hasLocation W20964185482 @default.
• W2096418548 hasOpenAccess W2096418548 @default.
• W2096418548 hasPrimaryLocation W20964185481 @default.
• W2096418548 hasRelatedWork W1954334858 @default.
• W2096418548 hasRelatedWork W1996158748 @default.
• W2096418548 hasRelatedWork W2069688734 @default.
• W2096418548 hasRelatedWork W2166546942 @default.
• W2096418548 hasRelatedWork W2169631870 @default.
• W2096418548 hasRelatedWork W2185070997 @default.

• next